Table 3.
Exploratory factorial analysis (EFA).
| Questions | Communalities | Component Matrix | |
|---|---|---|---|
| Q1 Prevalent chronic dermatoses | 0.640 | 0.182 | 0.113 |
| Q2 Factors of chronic dermatoses | 0.481 | 0.225 | 0.150 |
| Q3 Typical psoriasis lesions | 0.479 | 0.080 | 0.412 |
| Q4 Typical atopic dermatitis lesions | 0.594 | −0.063 | 0.394 |
| Q5 Typical seborrheic dermatitis lesions | 0.635 | −0.039 | 0.442 |
| Q6 Typical acne lesions | 0.412 | −0.044 | 0.558 |
| Q7 Prescribed medicines for psoriasis | 0.653 | 0.169 | 0.342 |
| Q8 Prescribed medicines for atopic dermatitis | 0.625 | −0.041 | 0.411 |
| Q9 Prescribed medicines for seborrheic dermatitis | 0.654 | 0.093 | 0.306 |
| Q10 Prescribed medicines for acne | 0.506 | 0.168 | 0.576 |
| Q11 Factors adherence chronic dermatoses | 0.407 | 0.341 | 0.375 |
| Q12 Appropriate instructions of medicines | 0.494 | 0.089 | 0.218 |
| Q13 Instruction duration corticosteroids | 0.652 | 0.610 | 0.313 |
| Q14 Instruction duration immunomodulators | 0.553 | 0.517 | 0.056 |
| Q15 Instruction duration anti-infectious | 0.732 | 0.758 | 0.169 |
| Q16 How to apply the medicine | 0.723 | 0.831 | 0.058 |
| Q17 How often apply cutaneous medicines | 0.810 | 0.869 | −0.021 |
| Q18 Indications of clear and precise dosing | 0.790 | 0.833 | −0.015 |
| Q19 Dosing instructions depend on… | 0.452 | 0.438 | −0.065 |
| Q20 Dimension of adherence to topical treatment | 0.545 | 0.230 | 0.083 |
| Q21 Increasing adherence to topical treatment | 0.697 | 0.767 | −0.091 |